The Cancer Research Center of the Albert Einstein College of Medicine was established in 1972, when it involved 23 investigators. The Center now comprises 64 investigators in 8 basic science and 7 clinical departments. They are funded for their research activities at a current annual total (direct costs only) of $20,696,759, exclusive of the Cancer Center Grant itself. The research programs of the Center fall into 8 major areas: Immunooncology, Viral Oncology, Gene Expression, Receptor-Mediated Growth and Differentiation, Growth Control in Malignant Cells, Membrane Synthesis and Structure, Carcinogenic and Therapeutic Agents, and Clinical Oncology. Of the 64 cancer investigators, 25 are housed in the Chanin Cancer Research Institute. That building also houses a number of Shared Services and Facilities including an Analytical Ultrastructure Center, Barrier Mouse Facility, Fluorescent Activated Cell Sorter, and facilities for Biohazard Research, Nucleic Acid Synthesis, Hybridoma Production and Cell Culture, and Transgenic Mice and Stem Cells. A laboratory for Macromolecular Analysis and a Nuclear Magnetic Resonance Facility are housed in adjoining buildings. The budget of the Cancer Center Grant as of June 1, 1990, the last year of the present grant, will be $1,925,420. It provides salary support for 24 cancer investigators including Senior Leadership Personnel, Major Program Directors, and the Directors of Shared Facilities; seed support for incoming new investigators who have not yet obtained personal research grants; interim support for investigators who are reapplying for grant support; and partial funding for 13 shared facilities and services, shared items of equipment, an expanding Clinical Research Program, and administration. This application is a request for the renewal of this Cancer Center Support Grant for an additional 5-year period, at the level of $2,721,560 in the first year.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-23
Application #
2086124
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1977-06-01
Project End
1996-05-31
Budget Start
1994-06-01
Budget End
1995-05-31
Support Year
23
Fiscal Year
1994
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
009095365
City
Bronx
State
NY
Country
United States
Zip Code
10461
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Guan, Fangxia; Tabrizian, Tahmineh; Novaj, Ardijana et al. (2018) Dietary Walnuts Protect Against Obesity-Driven Intestinal Stem Cell Decline and Tumorigenesis. Front Nutr 5:37
Yang, Chia-Ping Huang; Wang, Changwei; Ojima, Iwao et al. (2018) Taxol Analogues Exhibit Differential Effects on Photoaffinity Labeling of ?-Tubulin and the Multidrug Resistance Associated P-Glycoprotein. J Nat Prod 81:600-606
Chennamadhavuni, Divya; Saavedra-Avila, Noemi Alejandra; Carreño, Leandro J et al. (2018) Dual Modifications of ?-Galactosylceramide Synergize to Promote Activation of Human Invariant Natural Killer T Cells and Stimulate Anti-tumor Immunity. Cell Chem Biol 25:571-584.e8
Wang, Tao; Hosgood, H Dean; Lan, Qing et al. (2018) The Relationship Between Population Attributable Fraction and Heritability in Genetic Studies. Front Genet 9:352
Rocha, Agostinho G; Franco, Antonietta; Krezel, Andrzej M et al. (2018) MFN2 agonists reverse mitochondrial defects in preclinical models of Charcot-Marie-Tooth disease type 2A. Science 360:336-341
Limi, Saima; Senecal, Adrien; Coleman, Robert et al. (2018) Transcriptional burst fraction and size dynamics during lens fiber cell differentiation and detailed insights into the denucleation process. J Biol Chem 293:13176-13190
Vilchèze, Catherine; Copeland, Jacqueline; Keiser, Tracy L et al. (2018) Rational Design of Biosafety Level 2-Approved, Multidrug-Resistant Strains of Mycobacterium tuberculosis through Nutrient Auxotrophy. MBio 9:
Cabahug-Zuckerman, Pamela; Stout Jr, Randy F; Majeska, Robert J et al. (2018) Potential role for a specialized ?3 integrin-based structure on osteocyte processes in bone mechanosensation. J Orthop Res 36:642-652

Showing the most recent 10 out of 1508 publications